Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07126431) titled 'Prospective Cohort Study on Refractory Rheumatoid Arthritis' on Aug. 11.
Study Type: Observational
Primary Sponsor: Peking University Third Hospital
Condition:
Rheumatoid Arthritis
Recruitment Status: Recruiting
Date of First Enrollment: January 1, 2023
Target Sample Size: 200
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07126431
Disclaimer: Curated by HT Syndication....